Company Filing History:
Years Active: 2024
Title: Lewis Daniel Turner: Innovator in Pyrrolo[2,1-f][1,2,4]triazine Compounds
Introduction
Lewis Daniel Turner is a notable inventor based in San Diego, California. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on pyrrolo[2,1-f][1,2,4]triazine compounds. His research focuses on the therapeutic applications of these compounds in treating various diseases.
Latest Patents
Turner holds a patent for pyrrolo[2,1-f][1,2,4]triazines and their preparation and uses. This patent discloses the potential of pyrrolo[2,1-f][1,2,4]triazine compounds in treating disorders characterized by the overexpression of DYRK1A. These disorders include cancer, Down syndrome, Alzheimer's disease, diabetes, viral infections, and osteoarthritis. His work represents a significant advancement in the search for effective treatments for these challenging conditions.
Career Highlights
Lewis Daniel Turner is currently associated with Biosplice Therapeutics, Inc., where he continues to develop innovative solutions in the field of biotechnology. His expertise and dedication to research have positioned him as a key figure in the development of new therapeutic agents.
Collaborations
Turner collaborates with talented professionals in his field, including Gopi Kumar Mittapalli and Sunil Kumar K C. These collaborations enhance the research efforts at Biosplice Therapeutics, Inc. and contribute to the advancement of medical science.
Conclusion
Lewis Daniel Turner is a pioneering inventor whose work on pyrrolo[2,1-f][1,2,4]triazine compounds holds promise for treating various diseases. His contributions to medicinal chemistry and ongoing research efforts are paving the way for innovative therapeutic solutions.